US Recommends ‘Pause’ for J&J Shots in Blow to Vaccine Drive
By Zeke Miller, Lauran Neergaard, and Matthew Perrone, Associated Press
Published April 14, 2021
The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. (AP Photo/Mary Altaffer, File)
The U.S. on Tuesday recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were looking into unusual clots in six women between the ages of 18 and 48. One person died.
WASHINGTON The U.S. on Tuesday recommended a âpauseâ in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were investigating unusual clots in six women between the ages of 18 and 48. One person died.
The acting FDA commissioner expected the pause to last only a matter of days. But the decision triggered swift action in Europe and elsewhere as the drugmaker and regulators moved to halt the use of the J&J vaccine, at least for now. Hundreds of thousands of doses were due to arrive in European countries this week. The European Union has been plagued by supply shortages, logistical problems and concerns over blood clots in a small number of people who received the AstraZeneca vaccine.
Associated Press
The Johnson & Johnson COVID-19 vaccine sits on a table at a pop-up vaccinations site the Albanian Islamic Cultural Center in the Staten Island borough of New York. (AP Photo/Mary Altaffer, File)
WASHINGTON (AP) The U.S. on Tuesday recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were looking into unusual clots in six women between the ages of 18 and 48. One person died.
Should I be worried if I got the Johnson & Johnson vaccine?
Updated 9:33 AM;
Today 9:33 AM
Vials of the Johnson & Johnson vaccine to prevent COVID-19. The use of this particular vaccine has been halted temporarily. (Justin Tallis/AFP via Getty Images)
Facebook Share
By wire reports
The U.S. recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine after six women betweent the ages of 18 and 48 developed unusual blood clots. One woman died and another is in critical condition.
The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were looking into reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
Apr 14, 2021
WASHINGTON (AP) The U.S. on Tuesday recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
The Centers for Disease Control and Prevention and the Food and Drug Administration announced that they were looking into unusual clots in six women between the ages of 18 and 48. One person died.
The acting FDA commissioner expected the pause to last only a matter of days. But the decision triggered swift action in Europe and elsewhere as the drugmaker, regulators and providers moved to halt the use of the J&J vaccine, at least for now.